ARTICLE | Clinical News
Optison regulatory update
March 3, 2008 8:00 AM UTC
FDA added a boxed warning to the label of Optison to state that serious cardiopulmonary reactions, including fatalities, have occurred within 30 minutes following perflutren-containing microsphere adm...